If you are wondering whether DexCom shares are priced attractively right now or if the stock still carries a premium, this article breaks down what the current market price might be implying about the ...
StockStory.org on MSN
DexCom (NASDAQ:DXCM) exceeds Q1 CY2026 expectations but stock drops
Medical device company DexCom (NASDAQ:DXCM) reported Q1 CY2026 results , with sales up 15% year on year to $1.19 billion. The ...
StockStory.org on MSN
DexCom (DXCM) Q1 earnings: What to expect
Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings this Thursday after market close. Here’s what ...
Dexcom G7 CGMs contain a complex electronic assembly within a wearable package that stands up to the rigors of everyday ...
It has been about a month since the last earnings report for DexCom (DXCM). Shares have lost about 7% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the ...
DexCom (NASDAQ:DXCM) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings, ...
The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than 18 with diabetes. It's the longest-lasting system on the market. The G7 ...
DexCom (NASDAQ:DXCM) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below offers a condensed view of their recent ratings, ...
Glucose-monitoring specialist Dexcom announced it is expanding its diabetes-management capabilities by offering direct connectivity to the Apple Watch for its G7 continuous glucose monitoring system ...
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (DXCM) (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results